Indeed, in multiple myeloma, acute lymphoblastic leukemia, and other hematological cells, CD38 was abnormally upregulated and resulted in clinical manifestations of the disease include signs of organ dysfunction, along with an immunosuppressive microenvironment that finally led to hematological cells aggressiveness and poor prognosis [25, 26]. Here, CD38 is linked to acute lymphoblastic leukemia.